Myelin glycolipids and their functions

Current Opinion in Neurobiology

Volumn 7, Issue 5, 1997, Pages 654-661

  Stoffel, Wilhelm ^a   Bosio, Andreas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GALACTOSYLCERAMIDE; GALACTOSYLTRANSFERASE; GLYCOLIPID; MYELIN;

CENTRAL NERVOUS SYSTEM; GENE DELETION; HUMAN; LIPID BILAYER; LIPOGENESIS; MYELIN SHEATH; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SCHWANN CELL;

EID: 0030808781     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(97)80085-2     Document Type: Article

References (43)

1. DeWille JW, Horrocks LA: Synthesis and turnover of myelin phospholipids and cholesterol. In Myelin, edn 3. Edited by Mȧrtenson RE. Boca Raton: CRC Press; 1992:207-231.
2. Thudichum JLW: A Treatise on the Chemical Constitution of the Brain. London: Baillière, Tindall and Cox; 1884.
3. Thierfelder H, Klenk E: The chemistry of cerebrosides and phosphatides. In Monographien aus dem Gesamtgebiet der Physiologie der Pflanzen und der Tiere, vol 19. Edited by Gildemeister M, Goldschmidt R, Neuberg C, Parnas J, Ruhland W. Berlin: Julius Springer Press; 1930:1-65.
4. O'Brien JS, Rouser G: The fatty acid composition of brain sphingolipids: sphingomyelin, ceramide, cerebroside, and cerebroside sulfate. J Lipid Res 1964, 5:339-342.
5. DeVries GH, Norton WT: The fatty acid composition of sphingolipids from bovine CNS axons and myelin. J Neurosci 1973, 22:251-257.
6. Kishimoto Y: Phylogenetic development of myelin glycosphingolipids. Chem Phys Lipids 1986, 42:117-128.
7. Ki PF, Kishimoto YY, Lattman EE, Stanley EF, Griffin JW: Structure and function of urodele myelin lacking α-hydroxy fatty acid-containing galactocerebrosides: slow nerve conductance and unusual myelin thickness. Brain Res 1985, 345:19-24.
8. Haas NS, Shipley GG: Structure and properties of N-palmitoleoylgalactosphingosine (cerebroside). Biochim Biophys Acta 1995, 1240:133-141.
9. Bunow MR: Two gel states of cerebrosides. Calorimetric and Raman spectroscopic evidence. Biochim Biophys Acta 1979, 574:542-546.
10. Curatolo W: Phase behavior of galactocerebrosides from bovine brain. Biochemistry 1985, 24:6608-6613.
11. Chen SC, Sturtevant JM: Thermotropic behavior of bilayers formed from mixed chain phosphatidylcholines. Biochemistry 1981, 20:713-718.
12. Curatolo W, Sears B, Neuringer LJ: A calorimetry and deuterium NMR study of mixed model membranes of 1 -palmitoyl-2- oleylphosphatidylcholine and saturated phosphatidylcholines. Biochim Biophys Acta 1985, 817:261-270.
13. Curatolo W: Thermal behavior of fractionated and unfractionated bovine brain cerebrosides. Biochemistry 1982, 21:1761-1764.
14. Pascher I, Lundmark M, Nyholm P, Sundell S: Crystal structures of membrane lipids. Biochim Biophys Acta 1992, 1113:339-373.
15. Koshy KM, Boggs JM: Partial synthesis and physical properties of cerebroside sulfate containing palmitic acid or α-hydroxy palmitic acid. Chem Phys Lipids 1983, 34:41-53.
16. Boggs JM, Koshy KM, Rangaraj G: Effect of fatty acid chain length, fatty acid hydroxylation, and various cations on phase behavior of synthetic cerebroside sulfate. Chem Phys Lipids 1984, 36:65-89.
17. Honke K, Yamane M, Ishii A, Kobayashi T, Makita A: Purification and characterization of 3′-phosphoadenosine-5′-phosphosulfate:GalCer sulfotransferase from human renal cancer cells. J Biochem 1996, 119:21-27.
18. Honke K, Tsuda M, Hirahara Y, Ishii A, Makita A, Wada Y: Molecular cloning and expression of cDNA encoding human 3′-phosphadenylylsulfate:galactosylceramide 3′-sulfotransferase. J Biol Chem 1997, 72:4864-4868. The authors describe the isolation of a cDNA clone encoding a human sulfotransferase that uses glycolipids as acceptor molecules. The gene was only expressed in a human renal cancer cell line and the predicted size of the mature protein (54 kDa) differed remarkably from that described for the mouse brain enzyme (31 kDa). The existence of other enzymes/isozymes involved in brain-specific sulfatide synthesis is discussed.
19. Sundaram KS, Lev M: Purification and activation of brain sulfotransferase. J Biol Chem 1992, 267:24041-24044.
20. Schulte S, Stoffel W: Ceramide UDP-galactosyltransferase from myelinating rat brain: purification, cloning, and expression. Proc Natl Acad Sci USA 1993, 90:10265-10269.
21. Schulte S, Stoffel W: UDP-galactose-ceramide galactosyltransferase and glutamate/aspartate transporter. Copurification, separation and characterization of the two glycoproteins. Eur J Biochem 1995, 233:947-953.
22. Bosio A, Binzcek E, Le Beau MM, Fernald AA, Stoffel W: The human gene cgt encoding the UDP-galactose-ceramide galactosyltransferase (cerebroside synthase): cloning, characterisation and assignment to human chromosome 4, band q26. Genomics 1996, 34:69-75.
23. Bosio A, Binczek E, Stoffel W: Molecular cloning and characterization of the mouse CGT gene encoding UDP-galactose-ceramide galactosyltransferase (cerebroside synthetase). Genomics 1996, 35:223-226.
24. Coetzee T, Li X, Fujita N, Marcus J, Suzuki K, Francke U, Popko B: Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose-ceramide galactosyltransferase. Genomics 1996, 35:215-222.
25. Linnington C, Rumsby MG: Accessibility of galactosyl ceramides to probe reagents in central nervous system myelin. J Neurochem 1980, 35:983-992.
26. Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfmann SH, Silberberg DH, Gregson NA, Leibowitz S, Kennedy CM: Galactocerebroside is a specific cell surface antigenic marker for oligodendrocytes in culture. Nature 1978, 274:813-816.
27. Dyer CA, Benjamins JA: Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J Neurosci 1988, 8:4307-4318.
28. Bansal R, Pfeiffer SE: Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci USA 1989, 86:6181-6185.
29. Ranscht B, Wood PM, Bunge RP: Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebrosides. J Neurosci 1987, 7:2936-2947.
30. Sommer I, Schachner M: Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 1981, 83:311-327.
31. Bansal R, Gard AL, Pfeiffer SE: Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 1988, 21:260-267.
32. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE: Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development J Neurosci Res 1989, 24:548-557.
33. 2+ responses in oligodendrocytes. J Neurosci Res 1991, 30:699-711.
34. Benjamins JA, Dyer CA: Glycolipids and transmembrane signaling in oligodendroglia. Ann NY Acad Sci 1990, 605:90-100.
35. Boison D, Stoffel W: Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid-deficient mice. Proc Natl Acad Sci USA 1994, 91:11709-11713.
36. Li C, Tropak MB, Gerial R, Clapoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J: Myelination in the absence of myelin-associated glycoprotein. Nature 1994, 369:747-750.
37. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner DA, Wintergest ES, Nave KA et al.: Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994, 13:229-246.
38. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
39. Bosio A, Stoffel W: Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci USA 1996, 93:13280-13285. This paper, together with Coetzee et al. [40••], reports the generation of a UDP-galactose-ceramide galactosyltransferase (cgt) null mutant mouse. Analysis of this mouse has permitted studies aimed at understanding galactocerebroside biosynthesis and the role played by galactocerebrosides and sulfatides in myelin sheath and oligodendrocyte differentiation, cgt-deficient mice exhibit a severe dysmyelinating phenotype. Reduced conduction velocity of the sciatic nerve as well as the characteristics of compound action potentials recorded from the spinal cord point to a complete loss of the insulation properties (ion impermeability) of the myelin membrane.
40. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B: Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and region instability. Cell 1996, 86:209-219. This paper independently reports the generation of a UDP-galactose-ceramide galactosyltransferase (cgt) null mutant mouse.
41. Bosio A, Büssow H. Stoffel W: Galactosphingolipids and axonoglial interaction in myelin of central nervous system. Cell Tissue Res 1997, in press.
42. Caspar DL, Kirschner DA: Myelin membrane structure at 10Å resolution. Nat New Biol 1971, 231:46-52.
43. Bosio A, Binzcek E, Haupt W, Stoffel W: Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice. J Neurochem 1997, in press.